top of page
Search
  • Writer's picturePhilip Hockberger

Northwestern’s Chemistry of Life Processes Institute Hatches IPO of the Decade

January 28, 2020 - What happens when a highly interdisciplinary and integrated team of scientists, business leaders and students work together across fields of fundamental science, discovery, development, and finance? In the case of Monopar Therapeutics, a Chemistry of Life Processes Institute-affiliated spin-out, it leads to a record-breaking initial public offering.


Last month, Monopar (MNPR), a clinical stage biopharmaceutical company that develops proprietary therapeutics for cancer, experienced the “best first-day pop for an IPO since Baidu in 2005,” according to Nasdaq News. The company’s stock price rocketed 231 percent from its initial offering, reaching a market valuation of $289 million on its first day.


For more information, click here.

27 views0 comments

Recent Posts

See All

by John Pletz, Carin's Chicago Business, May 6, 2021 A Northwestern University drug-development spinout has raised $4 million from investors including Morningstar founder Joe Mansueto. Grove Biopharma

CBIA and Women In Bio (WIB) have published results of a survey that addresses the needs of professional women working in the life sciences. "The concept of work–life integration reflects a growing des

bottom of page